{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:31:13Z","timestamp":1766554273362,"version":"3.48.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06168-1","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:26:37Z","timestamp":1766553997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correspondence regarding \u201cEpidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette\u2013Gu\u00e9rin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims data\u201d"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8769-1584","authenticated-orcid":false,"given":"P\u0131nar","family":"Peker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"6168_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00345-025-06025-1","volume":"43","author":"J Luna","year":"2025","unstructured":"Luna J, Otte im Kampe E, Aga-Barfknecht H, Lehne M, Kunk L, H\u00e4nsel I, Trescher S, Mevius A, Kisser A, Kroeger N, De Santis M (2025) Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette\u2013Gu\u00e9rin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims data. World J Urol 43:661","journal-title":"World J Urol"},{"key":"6168_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/JU.0000000000003459","volume":"209","author":"EC Zabor","year":"2023","unstructured":"Zabor EC, Assel M (2023) On the need for landmark analysis or time dependent covariates. J Urol 209:1060\u20131062","journal-title":"J Urol"},{"key":"6168_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der Meijden APM, Lamm DL (2002) Intravesical Bacillus Calmette-Gu\u00e9rin reduces the risk of progression in superficial bladder cancer: a meta-analysis. J Urol 168:1964\u20131970","journal-title":"J Urol"},{"key":"6168_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","volume":"169","author":"A B\u00f6hle","year":"2003","unstructured":"B\u00f6hle A, Jocham D, Bock PR (2003) Intravesical BCG versus mitomycin C for superficial bladder cancer: meta-analysis of comparative studies. J Urol 169:90\u201395","journal-title":"J Urol"},{"issue":"1","key":"6168_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European association of urology guidelines on Non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in Situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"key":"6168_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles T, Bellmunt J, Comperat E et al (2022) ESMO clinical practice guidelines for bladder cancer. Ann Oncol 33:244\u2013258","journal-title":"Ann Oncol"},{"issue":"1","key":"6168_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euf.2023.07.002","volume":"10","author":"T Yanagisawa","year":"2024","unstructured":"Yanagisawa T, Kawada T, von Deimling M, Bekku K, Laukhtina E, Rink M et al (2024) Repeat transurethral resection for non-muscle-invasive bladder cancer: an updated systematic review and meta-analysis in the contemporary era. Eur Urol Focus 10(1):41\u201356","journal-title":"Eur Urol Focus"},{"key":"6168_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat TURBT in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73:925\u2013933","journal-title":"Eur Urol"},{"key":"6168_CR9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00345-018-2299-2","volume":"36","author":"J Palou","year":"2018","unstructured":"Palou J, Pisano F, Sylvester R et al (2018) Prognostic impact of stage at re-TUR in T1G3 bladder cancer treated with BCG. World J Urol 36:1621\u20131627","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06168-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:26:38Z","timestamp":1766553998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6168"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06168-1","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"64"}}